Organ Support & Automation Technologies (CRT3)
The mission of CRT3 is to deliver materiel and knowledge products that enhance Soldier survival at point of injury and during prolonged care outside of hospitals, as well as to develop, test, and validate new medical devices and systems using of state-of-the-art technologies in automation, advanced displays, artificial intelligence/machine learning, robotics, telemedicine, and computer vision to improve outcomes of combat casualties in current battlefields and future Multi-Domain Operations (MDO) where prolonged care (PC) or mass casualties are present.
Highlighted Major Capabilities
- Combat-relevant research trauma models
- Full round-the-clock intensive care unit studies continuing for 72 hours
- State of the art critical care equipment
- State of the art anticoagulation equipment and monitoring
- Medical device development, 3-D printing, and fabrication
- Data processing
- State of the art immunomodulation assessment capabilities
- Damage-Associated Molecular Pattern and Pathogen-Associated Molecular Pattern - assessment and histopathology
- Automation, artificial intelligence, and machine learning
- Application development and computer programming
- Medical Simulations
2035 "paradigm-changing" efforts include:
- Biologically friendly partial organ support
- Wearable critical care and full multi-organ support platform for conscious ambulation without mechanical ventilation
- Work across CRTs to support product development
While moving toward these goals:
- Delivering fully autonomous surgical capability for damage control surgery at the point of need
- Develop novel algorithms to support software development